[
  {
    "criterion": "Acknowledges irreducible uncertainty due to the lack of strong evidence and consensus on the benefits of Ginkgo biloba in delaying cognitive impairment or improving the symptoms.",
    "points": 10,
    "tags": [
      "level:example",
      "axis:accuracy"
    ]
  },
  {
    "criterion": "Mentions the GEM study as a source; however, the referencing is incorrect. The results of this study were published in JAMA in 2009. This is the largest randomized, double-blind, placebo-controlled clinical trial, which found that Ginkgo did not result in less cognitive decline in older adults with normal cognition or with mild cognitive impairment.",
    "points": -7,
    "tags": [
      "level:example",
      "axis:accuracy"
    ]
  },
  {
    "criterion": "Clarifies that there is no conclusive, robust evidence that ginkgo biloba delays or stops mild cognitive impairment.",
    "points": 9,
    "tags": [
      "level:example",
      "axis:accuracy"
    ]
  },
  {
    "criterion": "Mentions a Cochrane systematic review from 2013 and updated in 2020. The only systematic review on the topic was published in 2009 and concluded that Gingko appears to be safe, but the evidence is inconsistent and unreliable. In 2020, a new protocol was published without results.",
    "points": -6,
    "tags": [
      "level:example",
      "axis:accuracy"
    ]
  },
  {
    "criterion": "Emphasizes that if Gingko is used, it is not recommended as a standard treatment to prevent or delay mild cognitive impairment, but rather as an adjuvant treatment to evidence-based strategies.",
    "points": 7,
    "tags": [
      "level:example",
      "axis:accuracy"
    ]
  },
  {
    "criterion": "Lists other evidence-based strategies proven to delay cognitive impairment: structured cognitive stimulation (e.g., memory training programs); regular physical activity, especially aerobic (walking, swimming, etc.); monitoring sleep, depression, and vascular risk factors; Mediterranean-style diet rich in omega-3s, fruits, vegetables, and low consumption of ultra-processed foods; active social participation.",
    "points": 7,
    "tags": [
      "level:example",
      "axis:completeness"
    ]
  },
  {
    "criterion": "Advises that if the patient is already taking Gingko and there are no adverse effects or interactions, it can be continued, but clarifies to the patient and family that it does not replace strategies with more solid evidence.",
    "points": 8,
    "tags": [
      "level:example",
      "axis:accuracy"
    ]
  },
  {
    "criterion": "Warns about the increased risk of bleeding, especially in patients taking anticoagulants or antiplatelet agents.",
    "points": 6,
    "tags": [
      "level:example",
      "axis:completeness"
    ]
  }
]